Tel: (01223) 748692
Elka graduated from Sheffield University in 2006 with a BSc in Biomedical Science. In 2007 she joined the Primary Care Unit as a Research Assistant working on the MoleMate Trial; assessing whether the use of a new, non-invasive diagnostic tool would lead to a more accurate assessment of suspicious pigmented lesions in primary care, and therefore earlier diagnosis of malignant melanoma. In 2010 she took up a position with University College London as a Trial Coordinator of a biliary tract cancer drug trial, and later moved to Windsor to manage a quality improvement programme for the European Association for Cardio-Thoracic Surgery.
In 2014 Elka re-joined the Primary Care Unit to undertake an MRC Sackler Prize funded PhD within the Cancer Group, under the supervision of Dr Fiona Walter. Her research focuses on timely diagnosis of oesophageal and gastric cancer.
Research interests include timely diagnosis of cancer, quality improvement in healthcare, and the use of mixed methods techniques in research.
Wilson ECF, Emery JD, Kinmonth AL, Prevost AT, Morris HC, Humphrys E, et al. The Cost-Effectiveness of a Novel SIAscopic Diagnostic Aid for the Management of Pigmented Skin Lesions in Primary Care: A Decision-Analytic Model. Value in Health 2013, 16:356-366.
Walter FM, Morris HC, Humphrys E, Hall PN, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ 2012; 345: e4110.
Royal College of General Practitioners Research Paper of the Year 2012: Cancer Category
Walter FM, Morris HC, Humphrys E, Hall PN, et al. Protocol for the MoleMateTM UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379]. BMC Family Practice 2010,11:36.
Walter FM, Humphrys E, Tso S, et al. Patient understanding of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study. BMC Family Practice 2010, 11:62.